PDPN and lip and oral cavity carcinoma: Their pooled sample partially overlapped with ours, and the meta-analytic findings were in line with our results, confirming that podoplanin overexpression was significantly associated with an increased risk of oral cancer development, with progressively higher podoplanin expression levels across the disease spectrum (i.e., normal oral mucosa < OPMD < OSCC) [11].